This article analyzes how algorithmic bias in AI medical screening perpetuates health disparities, drawing on clinical evidence from diabetic retinopathy…
AI transforms eye diagnostics amid ethical crossroads
Ophthalmic AI tools show 35-40% accuracy gains in diabetic retinopathy screening, driving market growth to $2.1B. Recent FDA clearances and…